Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis.
An exploratory systematic review and dose-response meta-analysis of the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) may increase the risk of obesity in adults.